B. Hirschel

Discipline

Psychologie (3) Sociologie (2) Economies et finances (2) Anthropologie biologique (2)

Type de document

Articles (40) Recensions (1) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Treatment (32) thérapie (31) Therapeutics (31) Human beings (30) cohorte (28) Patients (27) Patients (27) virus (25) adulte (23) Methods (23) Immunodeficiency (23) Swiss (23) Methods (23) adulte (23) Older people (21) infection (15) Infection (15) Use (15) Ci (Chinese poetry) (14) temps (durée) (13) risque (13) Time (13) Risk (13) RNA (13) Confidence (13) art (10) Art (10) Art (10) Art (10) Models (10)

Documents écrit par B. Hirschel (41) | parle de B. Hirschel (0)

Sensing the (digital) pulse. Future steps for improving the secondary use of data for research in Switzerland.
A. Martani et al. (2023)
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.
D. Carballo et al. (2015)
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
C. Granziera et al. (2013)
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients.
N. Beerenwinkel et al. (2013)
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.
C.A. Siegrist et al. (2012)
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
V. von Wyl et al. (2012)
Microstructural alterations in the brain of well treated HIV+ patients with minor neurocognitive disorders: a multi-contrast MRI study at 3T
C. Granziera et al. (2012)
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
T.R. Glass et al.
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
J. di Iulio et al.
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.
B. Hasse et al. (2011)
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
R. Lubomirov et al. (2011)
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB?) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection.
L. Elzi et al. (2011)
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.
R.D. Kouyos et al. (2011)
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.
V. von Wyl et al. (2011)
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
A.U. Scherrer et al. (2011)
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
M. Ortiz et al. (2011)
Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
V. Von Wyl et al. (2011)
HIV-associated neurocognitive disorders (HAND): a changing pattern
S. Simioni et al. (2011)
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
J. Fehr et al. (2011)
A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.
G. Wandeler et al. (2011)
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia.
T. Ferry et al. (2010)
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
S. Alizon et al. (2010)
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
M. Rotger et al. (2010)
Long-Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment-Experienced Patients in Switzerland.
V. von Wyl et al. (2009)
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
M. Ballif et al. (2009)

next